Stocks were indicated to open lower on Tuesday morning as continued profit-taking in September is a theme. Despite the choppy markets, it’s important to know that the major stock market indexes are still quite close to all-time highs. Investors also need to consider that buying the sell-offs has so far in 2018 been less rewarding than in prior years.

24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new ideas for investors and traders alike. Some analyst reports cover stocks to buy, but some cover stocks to sell or to avoid.

Additional commentary has been added on most of the daily analyst reports, along with trading history. The consensus analyst price targets and other valuation metrics are from the Thomson Reuters sell-side research service.

These are the top analyst upgrades, downgrades and initiations seen on Tuesday, September 11, 2018.

American Electric Power Co. (NYSE: AEP) was reiterated as Overweight and the target price was raised to $80 from $76 at Morgan Stanley.

Baker Hughes, a GE Company (NYSE: BHGE) was started as Buy and assigned a $40 target price (versus a $31.93 prior close) at Stifel.

Caesars Entertainment Corp. (NASDAQ: CZR) was started as Outperform and the price target was set at $13 (versus a $9.85 close) at Credit Suisse.

CBS Corp. (NYSE: CBS) was downgraded to Neutral from Buy and the target price was cut to $60 from $72 at UBS. The stock was down 1.5% at $55.20 on Monday and down another 0.5% at $54.90 in early indications on Tuesday.

Energen Corp. (NYSE: EGN) was downgraded to Hold from Buy at Argus, with the independent research firm citing the Diamondback Energy buyout.

Generac Holdings Inc. (NYSE: GNRC) was reiterated as Hold but the price target was raised to $62 from $56 (versus a $58.83 close) at Canaccord Genuity.

Halliburton Co. (NYSE: HAL) was started as Buy and assigned a $45 price target at Stifel.

Myriad Genetics Inc. (NASDAQ: MYGN) was trading lower after being maintained as Underweight and after the price target was cut to $25 from $30 at Barclays. Its shares were indicated down 4.5% at $44.64 in early indications as the brokerage firm expressed concerns with GeneSight’s potential for expanding its market.

National Oilwell Varco Inc. (NYSE: NOV) was started as Buy and the price target was set at $54 at Stifel.

Nike Inc. (NYSE: NKE) was raised to Buy from Hold and the price target was raised to $95 from $78 at Canaccord Genuity.

Novartis A.G. (NYSE: NVS) was raised to Buy from Neutral at Citigroup.

Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.